✦ LIBER ✦

Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

✍ Scribed by K.O. Castle; K.E. Hoffman; L.B. Levy; A.K. Lee; S. Choi; Q.N. Nguyen; S.J. Frank; T. Pugh; S.E. McGuire; D.A. Kuban

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Androgen Deprivation Therapy o

✍ M.H. Stenmark; F.Y. Feng; D.A. Hamstra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Dose-escalated radiation therapy for int

✍ Stanley L. Liauw; Janine Fricano; David Correa; Ralph R. Weichselbaum; Ashesh B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Short-term androgen deprivation therapy

✍ Zachary S Zumsteg; Michael J Zelefsky 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 105 KB

PSA Response to Neoadjuvant Androgen Dep

✍ Sean E. McGuire; Andrew K. Lee; Jasmina Z. Cerne; Mark F. Munsell; Lawrence B. L 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Androgen Deprivation Therapy in Patients

✍ A.D. Vassil; E.S. Murphy; C.G. Robinson; C.A. Reddy; N. Chehade; J.P. Ciezki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Continued Benefit to Androgen Deprivatio

✍ Matthew H. Stenmark; Kevin Blas; Schuyler Halverson; Howard M. Sandler; Felix Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB